Skip to content

Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous)

Phase 2 Study of Efficacy of Adhesive Tablets in Treating Oral Ulcers (Aphthous)

Status
Suspended
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00281723
Enrollment
50
Registered
2006-01-25
Start date
Unknown
Completion date
2007-05-31
Last updated
2007-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcer, Aphthous

Keywords

Aphthous, oral

Brief summary

Recurrent Aphthous Stomatitis (RAS) of the oral mucosa is a common and painful condition. Despite advances in therapeutic means there is still necessary to find a way to alleviate the local pain and discomfort induced by the mucosal ulceration. The hypothesis was to study the effectiveness and acceptance of a herbal adhesive tablets in the treatment of RAS. Participants in the study will be examined for oral lesions, will be instructed how to apply the oral-tablet, and will be interviewed during the follow-up period up to one week after the application.

Interventions

DRUGPro-Pe adhesive tablet

Sponsors

Grant from Axiomedic. Advanced Medical Solutions, Zurich, Switzerland
CollaboratorUNKNOWN
Hadassah Medical Organization
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

(in healthy individuals): * Age above 18 years old. * Non-pregnant women. * Healthy or controlled chronic diseases. * Examination at the Oral Medicine Clinic Inclusion Criteria (in RAS patients): * Age above 18 years old. * Non-pregnant women. * Clinical diagnosis of RAS. * Examination at the Oral Medicine Clinic

Exclusion criteria

* Oral lesion suspected to be malignant. * Ulcerative oral lesion other than RAS. * Another experimental oral intervention within the last 24 hours. * Pregnant women. * Allergy to components of the Pro-pe adhesive tablet

Design outcomes

Primary

MeasureTime frame
Serial questionnaires within 1 week post treatment to assess patient's perception, patient's pain relief and local adverse events in comparison to his past experience with other local treatments for oral ulcers.

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026